Home Compliance Teva and Glenmark Settle Drug Price-Fixing Allegations at an Expense of More... ComplianceNews Teva and Glenmark Settle Drug Price-Fixing Allegations at an Expense of More Than a Quarter-Billion Dollars August 23, 2023 41 Share FacebookLinkedinTwitter Aleksandra Gigowska | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance EEOC & DOJ Issue Guidance to Workers on Discrimination Related to DEI Programs Compliance The False Claims Act Could Become the New “It” Statute in an Uncertain Enforcement Landscape Compliance FCA Panel at 2025 ABA White Collar Conference Share Views on Cutting Edge Issues
